ADC Therapeutics SA USD 200 million private placement

•

By

CapLaw

Share on:

On 23 October 2017, ADC Therapeutics SA, an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it has raised USD 200 m through a private placement of shares. According to BioWorld.com, the placement is the fourth largest private financing round on record for a European biopharmaceutical firm and the second largest private equity round in European biopharma so far in 2017.

Back to the homepage
CapLaw Themes
CapLaw PDF Archive

Discover more articles

We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events.

  • BX DIGITAL: THE FIRST DLT TRADING FACILITY IN SWITZERLAND

    By

    Fabian Friedli

    BX Digital AG received the first license from FINMA to operate a DLT trading facility on 12 March 2025. It is also the first financial market infrastructure for the trading and settlement of DLT securities based on a public permissionless blockchain.

    Read more: BX DIGITAL: THE FIRST DLT TRADING FACILITY IN SWITZERLAND

  • Proposed Amendment of Swiss Capital Adequacy Ordinance regarding AT1 Instruments – a First Assessment by Practitioners

    By

    Stefan Kramer

    /

    Benjamin Leisinger

    On 6 June 2025, the Swiss Federal Council published proposed amendments to the Swiss Capital Adequacy Ordinance, including „more precise information on the term and suspension of interest payments for AT1 capital instruments.“ The authors question the necessity of these changes and warn against using opaque terms and „hard triggers“ without any exemptions.

    Read more: Proposed Amendment of Swiss Capital Adequacy Ordinance regarding AT1 Instruments – a First Assessment by Practitioners

  • Zürcher Kantonalbank‘s issuance of EUR 500 million Bonds  

    By

    CapLaw

    On 8 July 2025, Zürcher Kantonalbank successfully completed its issuance of EUR 500 million 2.762%. Fixed Rate Bonds due 2030 (the Bonds). The senior unsecured bonds have been issued under Zürcher Kantonalbank‘s Swiss base prospectus consisting of the applicable summary and securities note for the issue of bonds and STNs of Zürcher Kantonalbank dated 20…

    Read more: Zürcher Kantonalbank‘s issuance of EUR 500 million Bonds  

  • Merger of Aebi Schmidt Group and The Shyft Group with Listing on NASDAQ

    By

    CapLaw

    On 1 July 2025, the Swiss specialty vehicle manufacturer Aebi Schmidt announced the successful completion of its merger with The Shyft Group, thereby creating a world-class specialty vehicles leader with sales of approx. USD 2 billion per year and 70 locations worldwide. The shares of the combined Aebi Schmidt Group (NASDAQ: AEBI) started trading on…

    Read more: Merger of Aebi Schmidt Group and The Shyft Group with Listing on NASDAQ

  • Ultima Capital‘s Contribution of Nammos Mykonos

    By

    CapLaw

    Ultima Capital SA (Ultima), a Swiss luxury real estate owner and operator listed on BX Swiss, conducted its second contribution in kind of real estate assets by its largest shareholder Yoda PLC (Yoda). The contributed assets are pertaining to the Nammos Village and restaurant real estate in Mykonos, Greece. The assets were valued at EUR 133.7…

    Read more: Ultima Capital‘s Contribution of Nammos Mykonos

  • Raiffeisen‘s Inaugural Issuance of Green Bonds

    By

    CapLaw

    On 27 June 2025, Raiffeisen Schweiz Genossenschaft successfully completed its issuance of CHF 250 million 0.785% fixed rate green bonds due 2030 under its issuance program for money market instruments, bonds and green bonds. This issuance marks the first issuance of a green bond by Raiffeisen Schweiz Genossenschaft.  Raiffeisen Schweiz Genossenschaft acted as Sole Lead Manager…

    Read more: Raiffeisen‘s Inaugural Issuance of Green Bonds